Treatment of renal cell carcinoma: Current status and future directions-Reference-Cited by-全球学者库

Treatment of renal cell carcinoma: Current status and future directions

Published:2017-09-29 Issue:6 Volume:67 Page:507-524
ISSN:0007-9235
Container-title:CA: A Cancer Journal for Clinicians
language:en
Short-container-title:CA: A Cancer Journal for Clinicians

Author:

Barata Pedro C.¹^ORCID,Rini Brian I.²

Affiliation:

1. Experimental Therapeutics Fellow, Department of Hematology and Medical Oncology; Cleveland Clinic Taussig Cancer Institute; Cleveland OH

2. Professor of Medicine, Cleveland Clinic Lerner College of Medicine; and Leader, Genitourinary Program, Glickman Urological and Kidney Institute, Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute; Cleveland OH.

Funder

Merck, Roche, and Bristol-Myers Squibb

Publisher

Wiley

Subject

Oncology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.3322/caac.21411/fullpdf

Reference167 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Understanding the natural biology of kidney cancer: implications for targeted cancer therapy;Klatte;Rev Urol,2007

3. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

4. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

Cited by 555 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of molecular subtypes and diagnostic model in clear cell renal cell carcinoma based on collagen-related genes may predict the response of immunotherapy;Frontiers in Pharmacology;2024-02-05

2. Construction of a five-disulfidptosis-related-lncRNA signature for predicting prognosis and immune activity in kidney renal clear cell carcinoma;2024-02-05

3. Integrated single-cell and bulk characterization of branched chain amino acid metabolism-related key gene BCAT1 and association with prognosis and immunogenicity of clear cell renal cell carcinoma;Aging;2024-02-02

4. Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma;Aging;2024-01-29

5. LRP6 is a potential biomarker of kidney clear cell carcinoma related to prognosis and immune infiltration;Aging;2024-01-15